Meridian Bioscience Submits C. Difficile MDx Test to FDA

The C. difficile test is the first molecular diagnostic product for Meridian. It hopes to market the test later this year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories